Showing results (31-40 of 5,935) with videos related to
Sort By:
Pageof 594
Journal of Pediatric Hematology/Oncology|October 22, 2010
Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHDMarta González Vicent, Manuel Ramirez, Julián Sevilla, et al.Journal of Pediatric Hematology/Oncology|October 1, 2010
All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemiaPamir Işık, Ilker Çetin, Betul Tavil, et al.Journal of Pediatric Hematology/Oncology|July 15, 2010
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete responseEvangeline Brown, Andre Hebra, Joseph Jenrette, et al.Journal of Pediatric Hematology/Oncology|July 15, 2010
Isolated early onset anemia after rh isoimmunization: a unique presentation in 3 neonatesDeepak Louis, Sapna Oberoi, Venkataseshan Sundaram, et al.Journal of Pediatric Hematology/Oncology|August 6, 2010
A family-based randomized controlled trial of pain intervention for adolescents with sickle cell diseaseLamia P Barakat, Lisa A Schwartz, Katherine S Salamon, et al.Journal of Pediatric Hematology/Oncology|August 6, 2010
Impact of clinical pathway on quality of care in sickle cell patientsArchana Jayaram, Rollin W Nagel, Rama JastyJournal of Pediatric Hematology/Oncology|August 6, 2010
Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndromeParth Mehta, Robert I ParkerJournal of Pediatric Hematology/Oncology|August 26, 2010
Treatment of pediatric Burkitt lymphoma in TurkeyTiraje Tülin Celkan, Safa Bariş, Nihal Ozdemir, et al.Journal of Pediatric Hematology/Oncology|October 6, 2010
The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overloadMoshen S ElAlfy, Moshen El Alfy, Teny Tjitra Sari, et al.Journal of Pediatric Hematology/Oncology|November 11, 2010
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastomaGiselle L Saulnier Sholler, Genevieve M Bergendahl, Laurent Brard, et al.Pageof 594